Cargando…
Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies
The prognostic role of Extracellular matrix metalloproteinase inducer (EMMPRIN/ CD147) in gastrointestinal cancer remains controversial. We systematically reviewed the evidence of assessment of CD147 expression in gastrointestinal cancer to help clarify this issue. Pubmed, Embase, Cochrane Library a...
Autores principales: | Huang, Xiaohui, Shen, Weisong, Xi, Hongqing, Zhang, Kecheng, Cui, Jianxin, Wei, Bo, Chen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348372/ https://www.ncbi.nlm.nih.gov/pubmed/27768590 http://dx.doi.org/10.18632/oncotarget.12745 |
Ejemplares similares
-
Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease
por: von Ungern-Sternberg, Saskia N. I., et al.
Publicado: (2018) -
Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis
por: Calabro, Sarah R., et al.
Publicado: (2014) -
Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play
por: Chuliá-Peris, Lourdes, et al.
Publicado: (2022) -
Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis
por: Gao, Yunhe, et al.
Publicado: (2016) -
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features
por: Tian, Xiuyun, et al.
Publicado: (2015)